7 completed, 1 active not recruiting. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 7, Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow ilaprazole: new trials by email Literature Review of ilaprazole trials Research Report on ilaprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer Ilaprazole, Lansoprazole, Ilaprazole Placebo - Peptic Ulcer | Phase 3 | Active not recruiting | Il-Yang Pharm. Co., Ltd. | 416 | 2024-07-23 | 2026-11-06 |
| Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD Ilaprazole - Non-erosive Reflux Disease | Phase 3 | Completed | Il-Yang Pharm. Co., Ltd. | 277 | 2018-10-31 | 2021-01-05 |
| Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Ilaprazole, Omeprazole, Ilaprazole tablet - Peptic Ulcer Hemorrhage | Phase 3 | Completed | Livzon Pharmaceutical Group Inc. | 540 | 2014-10-01 | 2017-12-06 |
| Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment Ilaprazole, Pantoprazole - Peptic Ulcer | Phase 3 | Completed | Il-Yang Pharm. Co., Ltd. | 323 | 2012-12-01 | 2014-06-03 |
| Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients 10 mg ilaprazole, 40mg esomeprazole - Gastroesophageal Reflux Disease | Phase 3 | Completed | Livzon Pharmaceutical Group Inc. | 550 | 2011-12-01 | 2016-08-09 |
| Efficacy Study of Ilaprazole to Treat Erosive Esophgitis Ilaprazole, Lansoprazole - Erosive Esophagitis, GERD | Phase 3 | Completed | Il-Yang Pharm. Co., Ltd. | 292 | 2010-07-01 | 2012-01-12 |
| Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients 5 mg ilaprazole, 10 mg ilaprazole, 10 mg Rabeprazole - Duodenal Ulcer | Phase 2 / Phase 3 | Completed | Livzon Pharmaceutical Group Inc. | 408 | 2008-08-01 | 2016-07-28 |
| Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3) 10 mg ilaprazole, 20 mg omeprazole - Duodenal Ulcer | Phase 3 | Completed | Livzon Pharmaceutical Group Inc. | 496 | 2005-09-01 | 2009-08-06 |
Duodenal Ulcer (2) · Gastroesophageal Reflux (2) · Peptic Ulcer (2) · Non-Erosive Reflux Disease (1) · Peptic Ulcer Hemorrhage (1)
Il-Yang Pharm. Co., Ltd. (4) · Livzon Pharmaceutical Group Inc. (4)
South Korea (4) · China (1)
DongHo Lee, MD.PhD (1) · JungSoo Song, M.D. (1) · Kim JinHo (1) · S R Lin, M.D (1)